Patient P-02048

Synthetic patientMETA-24 · Day 175 · 35–44 · M · baseline S02Steering view · 3D Open companion preview

Therapy response

Improving

Tolerance

Favorable

GI state

Deteriorating

Inflammatory state

Deteriorating

Nutritional resilience

Favorable

Discontinuation risk

31%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S02

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Inflammatory activity+10
GI instability+9
Toxicity+4
Nutritional resilience+3

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

66 min

worsening · -4.9 vs previous 14 d

Sleep duration

Wearable

6.5 h

stable · -0.0 vs previous 14 d

Energy level

Daily log

5.5/10

stable · +0.0 vs previous 14 d

Steps

Wearable

7,137

worsening · -411 vs previous 14 d

GI burden

Companion

32.6/100

worsening · +3.2 vs previous 14 d

Adherence

Companion

95.2 %

stable · -0.6 vs previous 14 d

Sleep quality

Wearable

44.1/100

worsening · -3.1 vs previous 14 d

Glucose, CGM daily mean

CGM

135 mg/dL

stable · +1.7 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 72 from the failing basin, 19 from restoration.

Good elements to keep

Butyrate producers intact
hidden · steering +7.5
Protein (supports)
perturbation · steering +7.1
Protein
supporter · GI -4.1 next day

Main detractors to watch

IL6 high-expression variant
hidden · steering -7.3
Alcohol
perturbation · steering -6
Ultra-processed food
perturbation · steering -4.4
Poor-sleep week
perturbation · steering -3
Alcohol
detractor · GI +3.2 next day
Ultra-processed food
detractor · GI +2.9 next day

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-4.1supporter · 95%
Alcohol
+3.2detractor · 95%
Ultra-processed food
+2.9detractor · 95%
Dietary fat load
+0.6no signal · 18%
Insoluble fibre
+0.4no signal · 15%
Simple carbohydrates
-0.2no signal · 15%
Caffeine
-0.2no signal · 15%
Histamine load
+0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
Inflammatory signalling ↑25
- DNAIL6 -174 variant raises baseline inflammatory tone

DNA

Fictional pharmacogenomic panel

IL6 -174 G/C
Higher inflammatory tone
CYP2D6 Normal metabolizer
Expected exposure
MTHFR C677T
Reduced folate turnover

Microbiome

Shannon diversity 3.6 · butyrate capacity 77/100

Akkermansia muciniphilaLow
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 63 ms
Sleep: 6.4 h
Steps: 6,449
Resting HR: 64 bpm

Daily log: GI score 33, nutritional resilience 60, adherence 95.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02483	44%	S06	BR-03	no change	64
P-02282	32%	S01	BR-03	no change	88
P-02280	31%	S07	BR-03	no change	50
P-02354	37%	S01	CR-01	improved	78
P-02491	45%	S09	DT-01	no change	65
P-02462	40%	S12	DT-01	improved	65
P-02518	38%	S17	DT-01	improved	68
P-02395	34%	S12	DT-01	improved	57
P-02218	33%	S01	DT-01	improved	61
P-02235	32%	S14	DT-01	improved	50
P-02274	32%	S15	DT-01	improved	50
P-02565	32%	S09	DT-01	no change	79